Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study.
about
Shotgun proteomics reveals specific modulated protein patterns in tears of patients with primary open angle glaucoma naïve to therapyEfficacy and patient tolerability of travoprost BAK-free solution in patients with open-angle glaucoma and ocular hypertension.Cytometric assessment of cytostatic and cytotoxic effects of topical glaucoma medications on human epithelial corneal line cells.Influence of benzalkonium chloride on langerhans cells in corneal epithelium and development of dry eye in healthy volunteers.The effects of topical antiglaucoma drugs as monotherapy on the ocular surface: a prospective study.Handling test of eye drop dispenser--comparison of unit-dose pipettes with conventional eye drop bottles.Cytotoxicity of prostaglandin analog eye drops preserved with benzalkonium chloride in multiple corneoconjunctival cell lines.Research on the stability of a rabbit dry eye model induced by topical application of the preservative benzalkonium chloride.Toxicity of antiglaucoma drugs with and without benzalkonium chloride to cultured human corneal endothelial cells.Evaluation of biomarkers of inflammation in response to benzalkonium chloride on corneal and conjunctival epithelial cells.Ocular surface alterations and topical antiglaucomatous therapy: a review.A randomized, controlled comparison of macroscopic conjunctival hyperemia in patients treated with bimatoprost 0.01% or vehicle who were previously controlled on latanoprostConjunctival goblet cells density and preservative-free tafluprost therapy for glaucoma: an in vivo confocal microscopy and impression cytology study.Effect of Korean Red Ginseng supplementation on dry eye syndrome in glaucoma patients - A randomized, double-blind, placebo-controlled study.Toxicological evaluation of preservative-containing and preservative-free topical prostaglandin analogues on a three-dimensional-reconstituted corneal epithelium systemIncidence and pattern of dry eye after cataract surgeryCorneal alterations induced by topical application of commercial latanoprost, travoprost and bimatoprost in rabbit.Trans-conjunctival aqueous humor outflow in glaucomatous patients treated with prostaglandin analogues: an in vivo confocal microscopy study.Effects of Long-Term Antiglaucoma Eye Drops on Conjunctival Structures: An In Vivo Confocal Microscopy StudyTrefoil factor family 1, MUC5AC and human leucocyte antigen-DR expression by conjunctival cells in patients with glaucoma treated with chronic drugs: could these markers predict the success of glaucoma surgery?Measurement of inflammatory cytokines by multicytokine assay in tears of patients with glaucoma topically treated with chronic drugs.Topical prostaglandin analogues and conjunctival inflammation in uveitic glaucomaReduction of quaternary ammonium-induced ocular surface toxicity by emulsions: an in vivo study in rabbitsTherapeutic Effects of Sodium Hyaluronate on Ocular Surface Damage Induced by Benzalkonium Chloride Preserved Anti-glaucoma MedicationsConjunctival changes and inflammatory aspects in rabbits' conjunctivas induced by fixed combinations of prostaglandin analogues and timolol maleate.Benefits of switching from latanoprost to preservative-free tafluprost eye drops: a meta-analysis of two Phase IIIb clinical trialsIn vitro and in vivo experimental studies on trabecular meshwork degeneration induced by benzalkonium chloride (an American Ophthalmological Society thesis).Conjunctival and corneal reactions in rabbits following short- and repeated exposure to preservative-free tafluprost, commercially available latanoprost and 0.02% benzalkonium chloride.Increased SPARC expression in primary angle closure glaucoma iris.Ocular Tolerability of Preservative-Free Tafluprost and Latanoprost: in vitro and in vivo Comparative Study.Comparison of the ocular tolerability of a latanoprost cationic emulsion versus conventional formulations of prostaglandins: an in vivo toxicity assayBimatoprost 0.01% vs bimatoprost 0.03%: a 12-month prospective trial of clinical and in vivo confocal microscopy in glaucoma patientsBenzalkonium chloride and glaucoma.A Comparison of the Effects of Benzalkonium Chloride on Ocular Surfaces between C57BL/6 and BALB/c Mice.Current and emerging medical therapies in the treatment of glaucoma.Effects of common topical antiglaucoma medications on the ocular surface, eyelids and periorbital tissue.Ocular surface disease in patients with ocular hypertension and glaucoma.Benefits of cetalkonium chloride cationic oil-in-water nanoemulsions for topical ophthalmic drug delivery.Preserving neural retina through re-emerging herbal interventions.Recovery after cataract surgery.
P2860
Q24338381-20057322-5649-4F8C-BAEE-6A853C9E924DQ30435051-8C9C8980-15E5-435B-8A85-CA61A484CBBBQ33510968-8F4A99D0-6001-4C0D-8678-C55ADE0F1A26Q33645778-7ED972D7-8C88-469F-992A-E34C1DF476ACQ33804831-3008A24F-BCB6-4A89-9796-34E19CEA5220Q33947558-331EF87A-3A02-4A1B-8D9B-D6A48EA32DC8Q34078656-A2793252-57C7-461E-97E6-66F8ED8E2361Q34206447-00DF3188-59A7-4F73-8EB4-35E13E721676Q34245277-F94788EE-371D-40B7-81C1-82DAF919993BQ34309959-64FABD66-59E7-4BCF-A0C7-C9F5EF1FFB23Q34318892-550888F8-924C-4952-B369-33C4EE64C205Q34399842-3F008F4A-22C4-4D36-B8E6-B3FFF98095F2Q34678488-F13228D6-715B-45F3-B19F-98BDB46A6F48Q34719257-9157669F-EF8B-42ED-967F-35740008E9F7Q34997199-F533D932-58C9-450E-92B8-3B68F6733506Q35050334-F0E0BB95-463E-4B98-8647-CFB961D706BFQ35121491-FC5DD771-E954-48C0-8A48-75F9FBF13B3AQ35175058-8A4A53AF-E821-413B-A34D-F20E590E37C8Q35690325-6E9E033C-AC3F-4B11-B0AA-0CCEF4A4144AQ35762703-BADF71D5-A441-46B7-B0AB-54176FC428D2Q35762859-9968AEBF-05DE-4B9E-9F4D-B4A3EB99A3C2Q36192495-A7FD7A12-F5E2-44E1-AC3C-2079131A9D95Q36478996-2831E302-F7BB-4146-923E-7375857B3950Q36498525-A3726E3C-CF06-4098-879E-DEC53A3C22D4Q36707207-A338504B-ABA0-4673-BD27-6FDD4A380294Q36710059-51C311A6-6DD2-41FB-8925-8273A90F0788Q36898923-08C7DD64-117F-44C2-BB0F-5150467F32A4Q36940995-C47BE4C8-50F3-4AF6-8468-6684DC8FFE55Q36946607-62F416AB-A8F1-49F8-90ED-6B6C978D94EAQ36985297-6EC0C848-88BB-4481-A672-219F66D747A5Q37318278-9A6991CC-7652-42C6-92B8-A16425734762Q37697869-420255FD-C185-4F3E-92A1-5F7AF91E9866Q37710684-C0BB9900-8E39-42E4-B0E6-AA986A3C3807Q37729041-37FBE2AE-C34C-41CE-9550-B35BF33C0934Q37853195-EEC33FC0-D5AC-4AD4-8A3D-A406651B1DBCQ37856242-3847AB24-0C69-4463-92A5-2645728F789CQ37866329-D8B7A394-AB3B-4AAD-A72F-FB3DAF0F604DQ38133883-D0170DFB-D9B8-4457-8B15-C5E0072E8915Q38211171-D2B234F0-5D7A-41A5-9AC9-773242B2A5DEQ38816679-9A887E4B-E847-4A84-9561-3A64AB10D617
P2860
Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Conjunctival proinflammatory a ...... an ex vivo and in vitro study.
@ast
Conjunctival proinflammatory a ...... an ex vivo and in vitro study.
@en
type
label
Conjunctival proinflammatory a ...... an ex vivo and in vitro study.
@ast
Conjunctival proinflammatory a ...... an ex vivo and in vitro study.
@en
prefLabel
Conjunctival proinflammatory a ...... an ex vivo and in vitro study.
@ast
Conjunctival proinflammatory a ...... an ex vivo and in vitro study.
@en
P2093
P356
P1476
Conjunctival proinflammatory a ...... an ex vivo and in vitro study
@en
P2093
Caroline Debbasch
Catherine Creuzot-Garcher
Pascale Hamard
Patrice Rat
Pierre-Jean Pisella
P304
P356
10.1167/IOVS.03-1067
P407
P577
2004-05-01T00:00:00Z